Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease

This publication has 44 references indexed in Scilit:

• Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease
  American Journal of Epidemiology, 2005
• Comparison of losartan and captopril on heart failure–related outcomes and symptoms from the losartan heart failure survival study (ELITE II)
  American Heart Journal, 2005
• The N‐terminal active centre of human angiotensin‐converting enzyme degrades Alzheimer amyloid β‐peptide
  European Journal of Neuroscience, 2005
• ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia
  Neuroscience Letters, 2004
• Systemic Catabolism of Alzheimer's Aβ40 and Aβ42
  Journal of Biological Chemistry, 2004
• A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity
  Human Molecular Genetics, 2004
• Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse
  Clinical Science, 2003
• Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
  The American Journal of Pathology, 1999
• An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
  Journal of Clinical Investigation, 1990
• An improved fluorometric assay of rat serum and plasma converting enzyme.
  Hypertension, 1985